Beneficial cardiovascular pleiotropic effects of statins.
about
A comprehensive review on metabolic syndromeStatins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysisCentral blood pressure and chronic kidney diseaseProteins and small molecules for cellular regenerative medicineStatins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studiesA point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive CardiologyOverview of guidelines for the management of dyslipidemia: EU perspectivesTargeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular DiseasesIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemStatin post-treatment provides protection against simulated ischemia in bovine pulmonary arterial endothelial cells.Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.The metabolic syndromeUnacylated ghrelin modulates circulating angiogenic cell number in insulin-resistant states.Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Statins are related to impaired exercise capacity in males but not females.Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.Effect of preoperative statin therapy on myocardial protection and morbidity endpoints following off-pump coronary bypass surgery in patients with elevated C-reactive protein level.Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot studyInfluence of previous statin therapy on cholesterol-lowering effect of ezetimibe.Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.Restenosis after renal artery angioplasty and stenting: incidence and risk factors.Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials.Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley ratsPerioperative clinical variables and long-term survival following vascular surgery.Statins: Can we advocate them for primary prevention of heart disease?Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction.Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.Evolving targets for lipid-modifying therapyRosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy.The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome.Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.Effects of ezetimibe added to ongoing statin therapy on C-reactive protein levels in hypercholesterolemic patients.HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.Pravastatin stimulates angiogenesis in a murine hindlimb ischemia model: a positron emission tomography imaging study with (64)Cu-NOTA-TRC105Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels.Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism.Treatment approaches for diabetes and dyslipidemia
P2860
Q21284500-00D0CED7-C74F-4121-BE9C-943FFA1A5AA0Q26746082-FB6095EE-7083-4F3B-B944-8E2A18E203BFQ26770734-9272AF1B-8240-44BE-92FD-0DF6DCDAB297Q26850495-326EBD59-ABA1-4534-8793-9A252817B2E2Q26864624-348D9F71-1F16-4D4F-AC9F-8EB7351A5EDBQ26866033-D392AE2A-61D4-4CC2-B435-5F4EE2489184Q28069411-04F64BBB-5E28-409D-B824-13790C34297CQ28073279-0E26967D-5FA5-4B9F-825C-409F4EF28595Q28388335-302208D9-0E4E-497E-96E9-2B8F3F6BEBADQ28389419-4F789544-2C23-4066-B8C1-F2E0B273A69DQ30431767-1B6F82DC-6B6E-426A-9528-479CF5611B28Q33557210-20D657F4-05E0-4240-AC0A-6FDA6D4E9F49Q33569142-66A3F6FE-844B-4300-A965-DD4873ABD363Q33749878-DF09F7B9-31E1-408E-A749-AAD9C71F9382Q33776230-F0904354-7EFE-4E03-8664-C9B9FD8B129DQ33803252-F68FF637-E571-4917-AE09-E1C07D75835FQ33816245-134A20C2-7517-4D95-B030-161419AA7FF1Q33830394-E4D30AF4-250C-4D00-BE01-35A2DED097E9Q33861562-DBEDD778-D991-4690-9488-AC2A2AA99C74Q33904404-0BD1E377-DBF0-418A-93DD-18CAA909328BQ33984025-8DD77E34-2A56-4827-8129-3B0326207546Q34000818-E024BFE9-B895-44E2-8F6B-118CD08EBA87Q34102885-E43CED86-E74B-4336-91E2-67DC9D30C39DQ34236781-3732439D-06A7-475C-831D-E2BC9E350D2BQ34269548-DE47D630-E2B0-414A-A498-5FEF1B7CF51AQ34404488-2ECDB13C-5584-4C6A-A220-332430AA276DQ34425102-543BEF94-C9D5-46EE-9090-B70478ED6FC0Q34574872-79D18C8A-9C2D-4FAB-99E3-51F383E9454EQ34709177-8BDD3B45-48B2-4214-AA65-87E46297B883Q34880292-EF25A06A-9A20-43DB-8B7C-D3F50DB3C827Q34979110-37AA4C58-D4F6-4C33-8B29-959DC0E09619Q34984092-B4AFD74B-057A-4D5E-B4AE-1A767DBB14A2Q35021842-DE8E758F-FF35-4488-B2AB-CEF8E058FDF2Q35026444-36F7FC5F-A3C6-4705-AD61-C431F93783ADQ35048374-E7C20F14-77E6-43F2-94F9-0A0513CB3DCEQ35065253-A6A76125-BBCD-4C05-9B58-29250FE09259Q35071225-EBDB9DF8-97FB-4060-A7DE-CA27760D3E44Q35074866-B1384A6C-F750-4A03-BA91-55583DBAEEACQ35237250-F7054FD6-22C6-4CB2-B63B-D574AC69C877Q35460295-D7A8FD5E-7292-4926-9680-CE667CC4A27A
P2860
Beneficial cardiovascular pleiotropic effects of statins.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Beneficial cardiovascular pleiotropic effects of statins.
@ast
Beneficial cardiovascular pleiotropic effects of statins.
@en
Beneficial cardiovascular pleiotropic effects of statins.
@nl
type
label
Beneficial cardiovascular pleiotropic effects of statins.
@ast
Beneficial cardiovascular pleiotropic effects of statins.
@en
Beneficial cardiovascular pleiotropic effects of statins.
@nl
prefLabel
Beneficial cardiovascular pleiotropic effects of statins.
@ast
Beneficial cardiovascular pleiotropic effects of statins.
@en
Beneficial cardiovascular pleiotropic effects of statins.
@nl
P1433
P1476
Beneficial cardiovascular pleiotropic effects of statins.
@en
P2093
Jean Davignon
P304
P356
10.1161/01.CIR.0000131517.20177.5A
P407
P433
23 Suppl 1
P577
2004-06-01T00:00:00Z